PIM1 and breast carcinoma: A potential therapeutic target for many cancers, including breast cancer, is constitutively active serine/threonine kinases: casein kinase 2 (CK2) and the proviral integration site for Moloney murine leukemia virus-1 (PIM-1) [1–6].